SEHK AK Medical Holdings Among 3 Stocks Possibly Undervalued According to Estimates
In This Article:
As global markets navigate the complexities of geopolitical tensions and economic shifts, the Hong Kong stock market has shown resilience, with the Hang Seng Index climbing 10.2% recently. Amidst these fluctuations, investors are keen to identify stocks that may be undervalued, presenting potential opportunities for those looking to capitalize on market inefficiencies. In this context, understanding what makes a stock potentially undervalued—such as strong fundamentals or overlooked growth prospects—can be crucial in making informed investment decisions.
Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| BYD Electronic (International) (SEHK:285) | HK$33.00 | HK$63.32 | 47.9% |
| Giant Biogene Holding (SEHK:2367) | HK$52.30 | HK$97.51 | 46.4% |
| Zhaojin Mining Industry (SEHK:1818) | HK$13.10 | HK$23.97 | 45.3% |
| Kuaishou Technology (SEHK:1024) | HK$50.85 | HK$89.18 | 43% |
| MicroPort NeuroScientific (SEHK:2172) | HK$10.50 | HK$18.87 | 44.4% |
| Yadea Group Holdings (SEHK:1585) | HK$13.28 | HK$23.07 | 42.4% |
| Shanghai INT Medical Instruments (SEHK:1501) | HK$30.00 | HK$56.11 | 46.5% |
| CSC Financial (SEHK:6066) | HK$9.75 | HK$17.79 | 45.2% |
| Hangzhou SF Intra-city Industrial (SEHK:9699) | HK$11.02 | HK$19.71 | 44.1% |
| Digital China Holdings (SEHK:861) | HK$2.97 | HK$5.83 | 49.1% |
We're going to check out a few of the best picks from our screener tool.
AK Medical Holdings
Overview: AK Medical Holdings Limited is an investment holding company that designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally, with a market cap of HK$5.32 billion.
Operations: The company's revenue segments include CN￥989.17 million from orthopedic implants in China and CN￥159.06 million from orthopedic implants in the United Kingdom.
Estimated Discount To Fair Value: 40.9%
AK Medical Holdings is trading at HK$4.95, significantly below its estimated fair value of HK$8.38, suggesting it is undervalued based on cash flows. Its earnings are projected to grow 28.7% annually over the next three years, outpacing the Hong Kong market's growth rate of 12.2%. Despite recent management changes and stable half-year earnings results, AK Medical shows potential for robust revenue growth at 24.7% per year compared to the market average of 7.4%.
MicroPort CardioFlow Medtech
Overview: MicroPort CardioFlow Medtech Corporation is a medical device company focused on developing and commercializing transcatheter and surgical solutions for structural heart diseases in China and internationally, with a market cap of HK$1.98 billion.